JBIO · Jade Biosciences Inc
United States · RS rating 36 · As of 2026-11-03
| Price | 14.57 USD |
|---|---|
| 1-day change | +4.6% |
| RS rating (overall / 1M / 3M / 12M) | 36 / 68 / 18 / 85 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 30 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -33.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +45.7% |
| Market cap (USD) | $1.2B |